Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sherfaraz K. Patel"'
Autor:
Juergen K. V. Reichardt, Phyllis J. Goodman, Frank Z. Stanczyk, Catherine M. Tangen, Alan R. Kristal, Lisa W. Chu, Ian M. Thompson, Adrie van Bokhoven, Ann W. Hsing, Sherfaraz K. Patel, Scott M. Lippman, Catherine A. Till, Elizabeth A. Platz, William D. Figg, Ashraful Hoque, Marian L. Neuhouser
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 21:1823-1832
Background: Finasteride, an inhibitor of 5α-reductase (type II), lowers intraprostatic dihydrotestosterone (DHT), which is reflected in serum as reduced 5α-androstane-3α,17β-diol glucuronide (3α-dG). It also modestly increases serum testosterone
Autor:
Debra Hawes, Malcolm C. Pike, Frank Z. Stanczyk, Karine Chung, Anna H. Wu, A. Rebecca Anderson, Darcy V. Spicer, Susan E. Downey, De Shawn L. Taylor, Linda Hovanessian-Larsen, Sherfaraz K. Patel, Celeste Leigh Pearce
Publikováno v:
Breast Cancer Research and Treatment
Oocyte donors have high serum estradiol (E2) levels similar to the serum levels seen in the first trimester of pregnancy. We report in this article our studies comparing cell proliferation, Ki67 (MIB1), and estrogen and progesterone receptor levels (
Autor:
Nigel J. Clarke, Doerthe Brueggmann, Heather R. Macdonald, Jenny Jaque, Colleen Azen, Frank Z. Stanczyk, Sherfaraz K. Patel
Publikováno v:
SpringerPlus
Optimal care for breast cancer patients undergoing aromatase inhibitor (AI) treatment is ensured when estradiol (E2) levels are adequately suppressed. To assess treatment efficacy accurately, it is important to measure the serum E2 levels using a wel
Publikováno v:
Fertility and sterility. 90(4)
IGF-1 levels increased, and IGF-2 and IGFBP-3 levels remained unchanged, in postmenopausal women following oophorectomy. The increase in IGF-1 likely results from decreased ovarian steroidogenic precursors resulting from removal of the hormonally act